Table 2. Transgenic AADC-positive fibers in striatum (caudate nucleus and putamen) and nucleus accumbens.
NHP ID (survival) | Caudate nucleus | Putamen | Nucleus accumbensa |
---|---|---|---|
Control group | |||
V002326 (1 month) | − | − | − |
V002215 (1 month) | − | − | − |
V002397 (3 months) | − | − | − |
V002458 (9 months) | − | − | − |
AAV2-hAADC low dose group | |||
V002243 (1 month) | +++ | +++ | − |
V002274 (1 month) | ++/+++ | ++/+++ | − |
V002254 (3 months) | + | + | − |
V002294 (3 months) | ++/+++ | ++/+++ | + |
V002100 (9 months) | +++ | ++ | ++ |
V002276 (9 months) | +++ | ++ | |
AAV2-hAADC high dose group | |||
V002332 (1 month) | +++ | ++ | − |
V002370 (1 month) | ++/+++ | ++/+++ | − |
V002224 (3 months) | +++ | ++/+++ | + |
V002304 (3 months) | ++/+++ | ++ | − |
V002325 (9 months) | ++ | +/++ | − |
V002450 (9 months) | +++ | +++ | + |
AADC-ir fiber staining rating: −, absent (endogenous AADC staining); +, low intensity/sparse fiber staining; ++, intermediate intensity/many positive fibers; +++, high intensity/dense fiber staining.
AADC-positive fibers were found only in nucleus accumbens core.